Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITONAVIR vs RIVASTIGMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITONAVIR vs RIVASTIGMINE: Safety Overview

Metric RITONAVIR RIVASTIGMINE
Total FAERS Reports 11,980 9,123
Deaths Reported 1,190 2,232
Death Rate 9.9% 24.5%
Hospitalizations 2,925 2,716
Average Patient Age 43.8 yrs 80.0 yrs
% Female Patients 43.8% 59.5%
FDA Approval Date Dec 3, 2020 Apr 21, 2000
Manufacturer AbbVie Inc. Novartis Pharmaceuticals Corporation
Route ORAL TRANSDERMAL
Marketing Status Discontinued Discontinued